FDA Inspection 1035711 — Braeburn Pharmaceuticals Inc.

Braeburn Pharmaceuticals Inc. — FEI 3012349378

The FDA completed an inspection of Braeburn Pharmaceuticals Inc. on Nov 28, 2017 in Princeton, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Nov 28, 2017
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Princeton, NJ (United States)

Additional details

Sponsor, Contract Research Organization

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.